The comparison of the clinical utility between two kinds of bowel preparations (NaP Tablets and PEG salt solution)

Not Applicable

• Conditions: The patients who need colonoscopy

• Registration Number: JPRN-UMIN000005385
• Lead Sponsor: TT Medical Center Tokyo, Gastroenterology Division

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-05-11
• Study Completion: 2013-05-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

Not provided

Exclusion Criteria

A. Those who are true of contraindication to NaP or PEG solution: 1. patients with congestive heart failure or unstable angina, 2. patients with long QT syndrome or critical ventricular arrhythmia, 3. patients with ascites, 4. patients with or suspected of ileus, 5. patients with or suspected of bowel perforation, 6. patients with toxic megacolon, 7. patients with critical renal failure including hemodialysis patients and patients with acute phosphate nephropathy and 8. patients with a history of hypersensitivity of NaP or PEG solution. (As to PEG solution only 4, 5 and 6 are true of contraindication.) B. Those who are under 20 years old or 75 years old or more, or those who are 65 years old or more taking medicine which affect renal blood flow or function (such as diuretic, angiotensin-converting enzyme inhibitor, angiotensin-receptor antagonist, NSAIDs ). C. Those who are severely constipated (those who habitually take purgative or those who have less than 3 bowel movements a week). D. Those who have had their digestive tract operated (except a history of appendicitis operation) E. Those women who are pregnant, breast-feeding, or suspected of being pregnant. F. In addition, those who are judged to be inappropriate by doctors.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The quality of overall colon cleansing.

Secondary Outcome Measures

Name	Time	Method
1. The quality of colon cleansing in each 6 lesion of colon (ileocecal lesion, ascending colon, transverse colon, descending colon, sigmoid colon and rectum). 2. The amount of time to reach the cecum 3. The success rate of reaching the cecum 4. The defecation condition and the patients tolerance (by questionnaire)